Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4181531 | L'Encéphale | 2015 | 4 Pages |
Abstract
Treating negative symptoms of schizophrenia is a major issue and a challenge for the functional and social prognosis of the disease, to which they are closely linked. First- and second-generation antipsychotics allow a reduction of all negative symptoms. The hope of acting directly on primary negative symptoms with any antipsychotic is not supported by the literature. However, the effectiveness of first- and second-generation antipsychotics is demonstrated on secondary negative symptoms.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
M. Maurel, R. Belzeaux, M. Adida, J.-M. Azorin,